NTRK1 and gastrointestinal stromal tumor: Sunitinib is an oral multi-targeted receptor tyrosine kinase inhibitor (RTKI) that is commonly used for the treatment of gastrointestinal stromal tumor (GIST), advanced renal cell cancer, and pancreatic cancer.